Back
Sandoz Group AG Vs. NLS Pharmaceutics Industry Stock Comparison
Buy
81
SDZXF
Sandoz Group AG
Last Price:
42.75
Seasonality Move:
4.39%
Sell
28
NLSP
NLS Pharmaceutics
Last Price:
2.03
Seasonality Move:
9.94%
Buy
81
Sandoz Group AG (SDZXF)
is a Buy
Is Sandoz Group AG a Buy, Sell or Hold?
- The current Sandoz Group AG [SDZXF] share price is $42.75. The Score for SDZXF is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- SDZXF is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
28
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $1.98. The Score for NLSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SDZXF Stock Price Chart
What is Sandoz Group AG's stock price today?
-
The Sandoz Group AG share price today is $42.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SDZXF is experiencing slight buying pressure.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $1.98
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight buying pressure.
SDZXF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 30.73 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.83 - 45.91) | Sell |
Bollinger Bands (100): | (40.45 - 44.57) | Buy |
NLSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 23.92 | Sell |
Chaikin Money Flow: | 443559 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.62 - 3.88) | Sell |
Bollinger Bands (100): | (3.56 - 7.08) | Sell |
SDZXF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.96 | Sell |
20-day SMA: | 44.68 | Sell |
50-day SMA: | 43.6 | Sell |
200-day SMA: | 37.89 | Buy |
8-day EMA: | 43.59 | Sell |
20-day EMA: | 44.2 | Sell |
50-day EMA: | 43.66 | Sell |
200-day EMA: | 38.89 | Buy |
NLSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.53 | Sell |
20-day SMA: | 3.05 | Sell |
50-day SMA: | 3.93 | Sell |
200-day SMA: | 6.46 | Sell |
8-day EMA: | 2.44 | Sell |
20-day EMA: | 2.98 | Sell |
50-day EMA: | 3.85 | Sell |
200-day EMA: | 8.57 | Sell |
Sandoz Group AG Earnings Growth & SDZXF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sandoz Group AG Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NLS Pharmaceutics Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |